Matches in Wikidata for { <http://www.wikidata.org/entity/Q65535717> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- Q65535717 description "clinical trial" @default.
- Q65535717 description "ensayu clínicu" @default.
- Q65535717 description "klinisch onderzoek" @default.
- Q65535717 description "клінічне випробування" @default.
- Q65535717 name "An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment" @default.
- Q65535717 name "An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment" @default.
- Q65535717 type Item @default.
- Q65535717 label "An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment" @default.
- Q65535717 label "An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment" @default.
- Q65535717 prefLabel "An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment" @default.
- Q65535717 prefLabel "An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment" @default.
- Q65535717 P1050 Q65535717-365586D1-59D4-47E4-8AA9-8CE85D532C17 @default.
- Q65535717 P1132 Q65535717-EA2DD7DF-5A60-484A-B557-72BB94D7085C @default.
- Q65535717 P1476 Q65535717-2B8C2BA8-908D-446A-851F-71284B6B0F0E @default.
- Q65535717 P17 Q65535717-0A731408-4CEC-4ED2-B9A8-527C6DC9098D @default.
- Q65535717 P17 Q65535717-0F7C658A-A27D-471B-9D30-A532AB8A992E @default.
- Q65535717 P17 Q65535717-3751150F-6C90-4E9E-9830-1E85AB5734A7 @default.
- Q65535717 P17 Q65535717-3D0F7870-4339-4AC2-A827-E4BC81772F84 @default.
- Q65535717 P17 Q65535717-43A1F249-5B29-4CD3-9EDC-4F2B618009A9 @default.
- Q65535717 P17 Q65535717-60CAA758-ABDE-4504-89AD-A913319A7D40 @default.
- Q65535717 P17 Q65535717-6C1B92F7-B08C-4715-8B4A-C1CCB403843F @default.
- Q65535717 P17 Q65535717-99428BD3-23A2-4D8B-9513-E54253630B7A @default.
- Q65535717 P17 Q65535717-9C38CCD1-4A0C-4C4E-A7B3-22E7AD2D1F4E @default.
- Q65535717 P17 Q65535717-A174EF9E-1D3B-4E46-A7E0-BC15D49D1144 @default.
- Q65535717 P17 Q65535717-A7981540-05D4-47DD-8C95-BA5504903027 @default.
- Q65535717 P17 Q65535717-AD4F25D8-6EB1-4AC4-AF88-11F7BBBD77BF @default.
- Q65535717 P17 Q65535717-BC14A632-8584-4DDA-B511-F25E3A3F0A1E @default.
- Q65535717 P17 Q65535717-D321CBBC-3602-427F-8D79-61DEB017CE0C @default.
- Q65535717 P17 Q65535717-E9EA723C-0E32-4ACA-94A9-4654101CB2D8 @default.
- Q65535717 P17 Q65535717-EE06F53B-A720-4BFA-AC47-8F41CBAAF49C @default.
- Q65535717 P2899 Q65535717-2F045347-6AF1-4A48-99C8-9E1794A2FC74 @default.
- Q65535717 P3098 Q65535717-85BB4126-6136-468F-BED6-4A6060F0F0E1 @default.
- Q65535717 P31 Q65535717-A1435990-62D9-47A2-95FF-F9886B370D28 @default.
- Q65535717 P580 Q65535717-FB6C0BB2-D63B-4F04-BCD5-84200C57CD65 @default.
- Q65535717 P582 Q65535717-4ADA16E3-80D8-4575-8F81-98C1ED53F51D @default.
- Q65535717 P6099 Q65535717-9B156B36-25DE-48CE-BD09-E3A0A1F7A4B8 @default.
- Q65535717 P8363 Q65535717-847C7C83-E65B-4943-B37A-EC7C22A6BE42 @default.
- Q65535717 P1050 Q12206 @default.
- Q65535717 P1132 "+272" @default.
- Q65535717 P1476 "A Randomized, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, 26-Week, Multicenter Study With a 26-Week Extension, to Evaluate the Efficacy, Safety and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment" @default.
- Q65535717 P17 Q142 @default.
- Q65535717 P17 Q155 @default.
- Q65535717 P17 Q16 @default.
- Q65535717 P17 Q183 @default.
- Q65535717 P17 Q211 @default.
- Q65535717 P17 Q218 @default.
- Q65535717 P17 Q258 @default.
- Q65535717 P17 Q29 @default.
- Q65535717 P17 Q30 @default.
- Q65535717 P17 Q31 @default.
- Q65535717 P17 Q36 @default.
- Q65535717 P17 Q408 @default.
- Q65535717 P17 Q664 @default.
- Q65535717 P17 Q668 @default.
- Q65535717 P17 Q833 @default.
- Q65535717 P17 Q96 @default.
- Q65535717 P2899 "+25" @default.
- Q65535717 P3098 "NCT01064414" @default.
- Q65535717 P31 Q30612 @default.
- Q65535717 P580 "2010-06-01T00:00:00Z" @default.
- Q65535717 P582 "2011-12-01T00:00:00Z" @default.
- Q65535717 P6099 Q42824827 @default.
- Q65535717 P8363 Q78089383 @default.